---
title: Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria #ğŸš§ æ–½å·¥ä¸­

### Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria

##### **Minimal change glomerulopathy (MCG, â€œminimal change diseaseâ€**)

â€¢Â Â Â Epidemiology: Most common cause of nephrotic syndrome in children, less common in adults

â€¢Â Â Â Pathophysiology:

-Â Â Â Defined by nephrotic-range proteinuria and kidney biopsy with little or no change to the glomerular structure on light microscopy

-Â Â Â Primary MCD is idiopathic

-Â Â Â Secondary MCD may be associated with atopic disease, mononucleosis, Hodgkinâ€™s lymphoma, medications (e.g., NSAIDS, interferon, lithium)

â€¢Â Â Â Treatment: Steroids 4â€“8 weeks, good prognosis

##### Focal segmental glomerulosclerosis (FSGS)

â€¢Â Â Â Epidemiology: Most common cause of nephrotic syndrome in black adults

â€¢Â Â Â Pathophysiology:

-Â Â Â Defined by proteinuria and scarring in scattered glomeruli on biopsy

-Â Â Â Primary FSGS may result from genetic mutations in podocyte proteins

-Â Â Â Secondary FSGS is associated with HIV (â€œcollapsingâ€ type), obesity, heroin use

â€¢Â Â Â Treatment:

-Â Â Â Steroids or calcineurin inhibitors: 40â€“60% achieve remission, others have refractory disease and often advance to ESRD.

-Â Â Â Can recur in the transplanted kidney and is thought to be due to a soluble factor that has yet to be identified.

-Â Â Â Plasmapheresis can be utilized to remove this soluble factor to help prevent recurrence.

##### Membranous glomerulopathy (MGN, â€œmembranous nephropathyğ”„¦)

â€¢Â Â Â Epidemiology: Second most common cause of nephrotic syndrome in U.S. adults after diabetic nephropathy

â€¢Â Â Â Pathophysiology:

-Â Â Â Primary MGN is associated with the anti-phospholipase A2 receptor (anti-PLA2R) antibody; majority of cases are primary

-Â Â Â Causes of secondary MGN: SLE, hepatitis B, solid tumor malignancy (lung, breast, and GI carcinomas), medications (penicillamine, NSAIDs, mercury, captopril)

â€¢Â Â Â Diagnosis: Diagnosis requires a kidney biopsy, which shows deposits of IgG and C3

â€¢Â Â Â Clinical features: Higher propensity for thromboembolic events (particularly renal vein thrombosis)

â€¢Â Â Â Treatment: Up to one-third of patients will experience spontaneous remission; treatment with immunosuppression is considered for patients with a poor prognosis.

-Â Â Â <4 g protein/day: Good prognosis for remission

-Â Â Â 4â€“8 g protein/day: Possible chance of remission

-Â Â Â >8 g protein/day: Poor chance of remission, start treatment immediately

